Financials data is unavailable for this security.
View more
Year on year Kalbe Farma Tbk PT had net income fall -18.20% from 3.38tn to 2.77tn despite a 5.24% increase in revenues from 28.93tn to 30.45tn. An increase in the cost of goods sold as a percentage of sales from 60.19% to 62.40% was a component in the falling net income despite rising revenues.
Gross margin | 37.20% |
---|---|
Net profit margin | 9.79% |
Operating margin | 12.58% |
Return on assets | 11.05% |
---|---|
Return on equity | 14.52% |
Return on investment | 14.27% |
More ▼
Cash flow in IDRView more
In 2023, cash reserves at Kalbe Farma Tbk PT fell by 717.35bn. However, the company earned 2.91tn from its operations for a Cash Flow Margin of 9.55%. In addition the company used 1.14tn on investing activities and also paid 2.44tn in financing cash flows.
Cash flow per share | 83.79 |
---|---|
Price/Cash flow per share | 21.20 |
Book value per share | 471.50 |
---|---|
Tangible book value per share | 423.17 |
More ▼
Balance sheet in IDRView more
Current ratio | 3.96 |
---|---|
Quick ratio | 2.47 |
Total debt/total equity | 0.0467 |
---|---|
Total debt/total capital | 0.0415 |
More ▼
Growth rates in IDR
SmartText is unavailable
Div yield(5 year avg) | 1.89% |
---|---|
Div growth rate (5 year) | 3.58% |
Payout ratio (TTM) | 47.12% |
EPS growth(5 years) | 2.67 |
---|---|
EPS (TTM) vs TTM 1 year ago | -6.51 |
More ▼